Genicular Artery Embolization Gains Traction as a Minimally Invasive Solution for Osteoarthritis Knee Pain

As the prevalence of osteoarthritis continues to rise globally, clinicians and patients alike are seeking alternatives to traditional treatment pathways that often culminate in joint replacement surgery. One procedure gaining increasing attention is Genicular Artery Embolization (GAE)—a minimally invasive, image-guided therapy designed to reduce chronic knee pain by targeting inflammation at its source.

Pioneered by Dr. Yuji Okuno from Japan – GAE is now being adopted by endovascular specialists as part of a broader shift toward less invasive, outpatient-based care.

Addressing the Treatment Gap in Knee Osteoarthritis

For decades, the standard progression of care for knee osteoarthritis has remained largely unchanged: conservative therapies such as physical therapy and medications are followed by gel and cortisone injections, with total knee replacement reserved for advanced cases.

However, a significant number of patients fall into a “treatment gap”—those who have recurrent or persistent pain but are either not ready for surgery or are poor surgical candidates.

GAE is emerging as a highly effective solution for this underserved population.

Rather than focusing on structural changes within the knee joint, the GAE procedure targets the pathological hyper vascularity associated with inflammation of the synovial membrane. Embolization of the synovial microvasculature results in the selective regression of pathological unmyelinated nerve pain fibers.  

How GAE Works

The procedure is performed using real-time fluoroscopic imaging, to map the arterial supply of the knee. Through a low profile system, a micro-catheter is advanced into the target vessels. Embolic agents are then delivered to selectively embolize the abnormal blood vessels associated with inflammation.

The procedure is typically completed in under 60 minutes and performed on an outpatient basis with local anesthesia and light sedation.

Clinical Evidence and Outcomes

Clinical studies evaluating GAE have demonstrated promising results in patients with mild to moderate knee osteoarthritis.

Reported outcomes include:

• Significant reductions in pain often the same day
• Improved joint function and mobility
• Sustained symptom relief lasting 12–24 months or longer in many patients
• Low complication rates compared to surgical interventions

Patient satisfaction rates have also been consistently high, particularly among individuals seeking to delay or avoid knee replacement.

Expanding Role of Image-Guided Therapies

The rise of GAE reflects a broader trend in medicine toward image-guided, minimally invasive procedures that prioritize faster recovery times and reduced procedural risk.

Advances in vascular imaging and outpatient management have enabled physicians to precisely identify and treat sources of inflammation, opening new possibilities for conditions traditionally managed through open orthopedic surgery.

This convergence of minimally invasive endovascular techniques and devices are reshaping how chronic musculoskeletal conditions are approached.

Physician Perspective

According to David Fox, MD, FACS, RPVI, a board-certified vascular surgeon at Fox Vein and Vascular in New York City, GAE represents a meaningful addition to the treatment spectrum for knee osteoarthritis.

“Many patients are not ready for joint replacement but have exhausted or failed conservative therapies,” Dr. Fox notes. “Genicular artery embolization allows us to address inflammation directly, using advanced imaging to precisely target the vessels contributing to pain.”

Dr. Fox, who has more than two decades of experience in minimally invasive vascular procedures, emphasizes the importance of patient selection and precise technique in achieving optimal outcomes.

Looking Ahead

While GAE does not reverse osteoarthritis or regenerate cartilage, its ability to provide sustained pain relief without surgery positions it as a valuable option in the evolving care pathway for knee pain.

As awareness grows and more clinical data becomes available, Genicular Artery Embolization is likely to play an increasingly important role in bridging the gap between conservative therapy and surgical intervention.